CCNA2 and melanoma: The Q1 cohort demonstrated significantly elevated expression of CCNA2, CCNB1, CCND1, and CDH2, indicating CDC25A’s potential regulatory role in coordinating melanoma cell cycle progression with EMT dynamics.